Ian James Nicholson
Presidente en BIOVENTIX PLC .
Fortuna: 829 706 $ al 30/04/2024
Origen de la red de primer grado Ian James Nicholson.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.
30
| Private Company | Investment Managers | 30 |
| Subsidiary | Miscellaneous Commercial Services | 22 | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.
18
| Non-Profit Organization | Miscellaneous Commercial Services | 18 |
17
| Public Company | Biotechnology | 17 |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom.
9
| Private Company | Biotechnology | 9 |
| Public Company | Miscellaneous Commercial Services | 7 | |
Advent Life Sciences LLP
 Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry.
6
| Subsidiary | Biotechnology | 6 |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom.
6
| Extinct | Biotechnology | 6 |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ian James Nicholson a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Investor Relations Contact | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Drugstore Chains | Director/Board Member Chairman | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| The University of Manchester | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
BenevolentAI Cambridge Ltd.
 BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services BenevolentAI Cambridge Ltd. develops novel small molecule therapeutics, in particular in the areas of CNS, pain and inflammation. It specializes in drug development, project management and translational medicine. The company was founded on November 26, 2003 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| University of London | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
SpringHill Management Ltd.
 SpringHill Management Ltd. Investment ManagersFinance SpringHill Management Ltd. (SpringHill) is a private equity fund management firm specializing in the field of life sciences, focusing upon early-stage investments and development capital. Located in Guildford, SpringHill was founded by Dr. Kim Tan. | Investment Managers | Founder Private Equity Investor | |
| The University of Nottingham | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
Idis Ltd.
 Idis Ltd. Drugstore ChainsRetail Trade Idis Ltd. supplies pharmaceuticals and allied services to the healthcare industry. the company was founded by Crane Michael and Gould Amanda in 1987 and is headquartered in Weybridge, The united kingdom | Drugstore Chains | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder | |
Abbott Laboratories Ltd.
 Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| DIUL GROUP | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Macrotarg Ltd.
 Macrotarg Ltd. BiotechnologyHealth Technology Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK. | Biotechnology | Director/Board Member Director/Board Member | |
Nicoventures Trading Ltd.
 Nicoventures Trading Ltd. Industrial ConglomeratesProducer Manufacturing Nicoventures Trading Ltd. researches, develops, manufactures and delivers tobacco harm reduction products and services. The firm provides innovative and sustainable solutions to global problems arising from smoking and smoking-related illnesses. The company develops ortfolio of products and services focused on smoking cessation and harm reduction, including user-friendly nicotine delivery systems and patient-focused smoking cessation and support services. The company was founded by Christopher John Lord and David Thomas Newns in September 2008 and is headquartered in Manchester, the United Kingdom. | Industrial Conglomerates | Chairman Director/Board Member | |
Mitre Group Ltd.
 Mitre Group Ltd. Miscellaneous Commercial ServicesCommercial Services Mitre Group Ltd. provides sports and stadia training services. The firm consults on providing apprenticeships, staff development courses and pre-employment programmes. It offers coach education, sports development, youth work, stadia safety, management and leadership, customer service, employability skills, health and safety and first aid. The company is headquartered in Derby, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Medical Distributors | Director/Board Member Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| HORIZON DISCOVERY GROUP PLC | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer | |
| NIOX GROUP PLC | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member | |
| ERGOMED | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Luxfold S.A.
 Luxfold S.A. BiotechnologyHealth Technology Luxfold S.A. designs and engineers protein structures. It offers protein three-dimensional structure. The company is headquartered in Luxembourg. | Biotechnology | Director/Board Member Founder | |
Clinigen CTS Ltd.
 Clinigen CTS Ltd. Medical DistributorsDistribution Services Part of Triley Bidco Ltd., Clinigen CTS Ltd. is a British company that provides investigator-initiated studies services to investigators, with managed regulatory pathways required for support of IIS & EAP programs. The company is based in Burton-On-Trent, UK and has more than 30 years ’ experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company helps Pharmaceutical and Biotech companies grant access to unlicensed medicines around the globe. Clinigen's controlled drug handling services include five DEA registrations: manufacturer, importer, exporter, distributor, and retail pharmacy services. The company also offers a Patient Advocate Fellowship. | Medical Distributors | Director/Board Member Director/Board Member | |
Clinigen Healthcare Ltd.
 Clinigen Healthcare Ltd. Medical DistributorsDistribution Services Part of Triley Bidco Ltd., Clinigen Healthcare Ltd. is a British company founded in 2007 that has more than 30 years of experience providing quicker and broader access to critical medicines in 130+ countries, pre- and post-launch. The company is based in Burton-on-Trent, UK. The company's investigator-initiated studies services provide smart solutions to investigators, with managed regulatory pathways required for support of IIS & EAP programs. Through the Clinigen Management Access, patient and healthcare professionals are granted access to the medicines they need. | Medical Distributors | Director/Board Member Director/Board Member | |
Clinigen SP Ltd.
 Clinigen SP Ltd. Pharmaceuticals: MajorHealth Technology Part of Iovance Biotherapeutics, Inc., Clinigen SP Ltd. is a British pharmaceutical company that manufactures and sells pharmaceutical products. The company is based in Burton-On-Trent, UK. The company was founded in 2013. Clinigen was acquired by Iovance Biotherapeutics, Inc. from Clinigen Holdings Ltd. on May 18, 2023 for $264.04 million. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Wichtig Publishing SRL | Director/Board Member Director/Board Member | ||
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director of Finance/CFO Director/Board Member | |
Diurnal Ltd.
 Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Part of Neurocrine Biosciences, Inc., Diurnal Ltd. is a European, British UK-headquartered specialty pharmaceutical company founded in 2004. The company is based in Cardiff, UK. The company is dedicated to developing lifelong treatments for rare and chronic endocrine conditions. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Orphalan SA
 Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Chief Executive Officer | |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Founder Chairman Founder | |
| Wichtig International Ltd. | Chairman Director/Board Member | ||
BenevolentAI Ltd.
 BenevolentAI Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Ltd. develops artificial intelligence applications. The company is based in London, UK. The British company was founded in 2015 by Kenneth Patrick Mulvany, Ivan Griffin, Michael Brennan. BenevolentAI was acquired by Odyssey Acquisition SA on April 22, 2022 for $1,087.33 million. | Packaged Software | Chairman Director/Board Member Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member Founder Chief Executive Officer | |
Tridek-One Therapeutics SAS
 Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Chief Executive Officer | |
DRI Healthcare Plc
 DRI Healthcare Plc Investment ManagersFinance DRI Healthcare Plc is a closed-ended investment company, which invests in a portfolio of cash flow generating healthcare royalty assets. The company was founded on December 13, 2019 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member Chairman | |
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer |
Estadísticas
Internacional
| Reino Unido | 33 |
| Estados Unidos | 14 |
| Francia | 3 |
| Israel | 2 |
| Luxemburgo | 2 |
Sectorial
| Health Technology | 22 |
| Consumer Services | 9 |
| Commercial Services | 9 |
| Finance | 4 |
| Distribution Services | 4 |
Operativa
| Director/Board Member | 496 |
| Corporate Officer/Principal | 167 |
| Chairman | 149 |
| Independent Dir/Board Member | 110 |
| Chief Executive Officer | 78 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Raj Bhikhu Parekh | 50 |
| Göran Albert Ando | 44 |
| Elmar Schnee | 31 |
| Peter George Lutz | 31 |
| Garry Watts | 31 |
| Patrick Volkert Vink | 30 |
| Ian Johnson | 29 |
| Francois Nader | 28 |
| Peter Allen | 27 |
| Jean Raby | 26 |
| Judith Ann Hemberger | 26 |
| Peter Stephen Keen | 25 |
| Mohammed Malik | 24 |
| Olivier Brandicourt | 23 |
| Kim Tan | 23 |
- Bolsa de valores
- Insiders
- Ian James Nicholson
- Conexiones Empresas
